Address: 112 LIGOVSKY PROSPECT, SAINT-PETERSBURG, 191119,Russia
Tel: +7 (812) 710-82-25
Web: http://www.polysan-ru.com/
Scientific Technological Pharmaceutical Firm ‘POLYSAN’ Ltd. was founded in December 1992. Since then ‘POLYSAN’ turned into Pharmaceutical Firm, which develops original preparations and is capable of meeting competition with both domestic and foreign companies. Nowadays the Firm ranks among the leaders of pharmaceutical industry in Russia and takes constant care of application of science and state-of-the-art technology achievements to production aiming further improvement of output quality.
The main goal of “POLYSAN” is development of original high-efficient medicinal preparations with reasonable price for patients.
The uniqueness of the company consists of organization the whole preparation cycle from idea to development and registration, production and sale. In order to fulfill the above task the Firm has modern Scientific laboratory, Pharmaceutical production complex in Saint Petersburg and Substances production complex “POLISINTEZ” Ltd. in Belgorod (South of Russia).
The preparations designed and produced by the Firm have been successfully sold on both domestic and foreign markets.
Scientific Technological Pharmaceutical Firm ‘POLYSAN’ has two directions of its activity.
Firstly – “POLYSAN” is specialized on development of preparations for treating “socially important” diseases that lead to the long disability, invalidity: mass viral infections (hepatitis B, C, flue infections, HIV), bacterial infections and heavy diseases such as acute cerebrovascular disorder (brain infarction), ischemia and others.
Secondly – “POLYSAN” is producer of metabolic preparations on succinic acid basis possessed anti-oxidantive activity.
Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion of Phase III clinical trials, the jab is increasingly being seen as a viable…
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally. However, with large-scale Phase III trials having not yet…
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates, priorities set forth by the country’s manufacturing association…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls and automated bots spread misinformation…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they…
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the Roszdravnadzor. You’ve since rejoined as director since 2007. The organization…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you give a brief…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment, and promote the interests of ACTO members. Can you…
You have said that AstraZeneca intends to be “in Russia for Russia” and the company has recently announced a large-scale investment in this country, financing a $150Mn domestic facility in…
See our Cookie Privacy Policy Here
